VE-303
PureTech Health
[]
. receives fast track designation for ve303 and presents phase 2 data at digestive disease week #ddw2023
MTIG is dedicated to enhancing the regulatory, investment, and commercial environment to accelerate microbiome therapeutic drug product development.